BMS 100 852
Generic Name: dasatinib
Pill imprint BMS 100 852 has been identified as Sprycel 100 mg.
Sprycel is used in the treatment of chronic myelogenous leukemia; leukemia; acute lymphoblastic leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy.
Sprycel 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Sprycel Images
- Generic Name:
- dasatinib
- Imprint:
-
BMS 100
852 - Strength:
- 100 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-0852
Advertisement
More Sprycel resources
Search Again
